Our Summary

This study compared the effectiveness of two commercially available eye antiseptics, povidone-iodine (PVI) and chlorhexidine (CLX), in reducing bacteria on the eye surface before eye surgery. 70 adults preparing for intraocular surgery were divided into two groups. One group used PVI and the other used CLX, both applying the antiseptics four times daily for three days before surgery. The researchers measured the amount of bacterial DNA on the eye surface before and after treatment. They found that CLX was more effective in reducing bacteria than PVI. Also, patients reported fewer side effects with CLX compared to PVI. Therefore, the study concluded that CLX is better at reducing bacteria on the eye surface and is better tolerated by patients than PVI.

FAQs

  1. What were the two antiseptics compared in the study for reducing bacteria on the eye surface?
  2. Which antiseptic was found to be more effective at reducing bacteria on the eye surface before ocular surgery, PVI or CLX?
  3. Did patients report fewer side effects with PVI or CLX?

Doctor’s Tip

A helpful tip a doctor might give a patient about ocular surgery is to follow the prescribed regimen for eye antiseptic use before surgery to reduce the risk of infection and ensure a successful outcome. In this case, using chlorhexidine (CLX) as an eye antiseptic may be more effective in reducing bacteria on the eye surface compared to povidone-iodine (PVI) and may have fewer side effects. It is important to discuss with your doctor the best antiseptic option for your specific situation and to follow their instructions carefully for optimal results.

Suitable For

The text does not provide information on the types of patients that are typically recommended ocular surgery.

Timeline

Before ocular surgery:

  1. Patient consults with eye surgeon to discuss the procedure and potential risks and benefits.
  2. Patient undergoes pre-operative tests and evaluations to assess eye health and determine the best course of treatment.
  3. Patient receives instructions on how to prepare for surgery, including stopping certain medications and avoiding food or drink before the procedure.
  4. Patient may be prescribed eye drops or other medications to help prepare the eye for surgery.
  5. Patient uses an eye antiseptic, such as PVI or CLX, to reduce bacteria on the eye surface in the days leading up to surgery.

After ocular surgery:

  1. Patient is monitored closely in the recovery room to ensure there are no immediate complications.
  2. Patient may experience blurred vision, discomfort, or light sensitivity in the hours following surgery.
  3. Patient is given instructions on how to care for the eye post-surgery, including using prescribed eye drops and avoiding certain activities that could strain the eye.
  4. Patient attends follow-up appointments with the eye surgeon to monitor healing and address any concerns or complications.
  5. Over time, the patient’s vision gradually improves as the eye heals and adjusts to the changes made during surgery.

What to Ask Your Doctor

  1. What are the potential risks and complications associated with ocular surgery?
  2. How long is the recovery period after the surgery and what can I expect during this time?
  3. Are there any specific pre-operative instructions I need to follow before the surgery?
  4. Will I need to stop taking any medications before the surgery?
  5. What type of anesthesia will be used during the surgery?
  6. What is the success rate of this type of surgery and what are the expected outcomes?
  7. How many times have you performed this type of surgery and what is your success rate?
  8. Are there any alternative treatment options available for my condition?
  9. Will I need any follow-up appointments after the surgery and how long will it take for my vision to fully stabilize?
  10. Are there any specific post-operative care instructions I need to follow to ensure a successful recovery?

Reference

Authors: Romano V, Ferrara M, Gatti F, Airaldi M, Borroni D, Aragona E, Rocha-de-Lossada C, Gabrielli F, Papa FT, Romano MR, Calza S, Semeraro F. Journal: Am J Ophthalmol. 2024 May;261:165-175. doi: 10.1016/j.ajo.2024.01.007. Epub 2024 Jan 10. PMID: 38211781